Prostate cancer currently affects up to 70% more men than in the 1990s. Besides lung cancer, skin cancer and colon cancer, it is the most common cancer in men in developed countries. Every year there are 670,000 newly diagnosed cases. The risk of the disease increases with age above 60, and about 95% of all cases are aged over 80.
A strong immune system can deal with cancer cells well and it destroys them; however, sometimes it needs help. PENOXAL stimulates the immune system and it helps to optimise its activity, which manifests effectively enough to fight cancer cells. The product may be taken during radiotherapy and chemotherapy as it helps to overcome some of its adverse effects. Moreover, it improves the function of digestive tract, liver, kidneys and other organs that are under a great stress during cancer treatments; in this way it enhances a healthy body functioning and an overall well-being. M.D. Anna Galambos, Pharm.Dr. Thomas Arndt and other doctors confirm in their statements about Penoxal that it is suitable food supplement to complement cancer treatments. Find out more about Penoxal users experience HERE.
The risk of prostate cancer is clearly associated with age, it affects primarily men aged over 60, but numbers of younger patients are rising. Genetic factors play some part, so a close relation to a patient affected with prostate cancer (father or brother) increases the risk up to twofold. One of possible causes is a hormonal imbalance of the male sex hormone testosterone. A significant but modifiable factor is an unhealthy lifestyle – smoking, diet high in fat, excess consumption of alcohol, lack of exercise. The risk of the disease is related to the immune system; if weak, it may stimulate malignancy.
Early stages are usually asymptomatic, often, they are revealed accidentally when different problems are being assessed. The disease may be identified due to elevated levels of prostate-specific antigen (PSA); however, high levels may also suggest hyperplasia (thickening) or prostate inflammation. Apart from general symptoms, more advanced tumours may be associated with a lack of appetite, weight loss, fatigue, and problems with urination; a frequent need to pass urine is typical including urination at night or urinary retention, and rarely, blood in urine may appear. Along with metastases usually in bones, back pain or hip and limb pain are added.
In order to detect cancer or other benign changes in time, men over 40 are recommended to attend annual examinations of the prostate that are done per rectum (via anus). Health is definitely worth the momentary discomfort. Often, boosting the immune system is underestimated, yet it plays a major role in combating the unwanted tumour growth.
Elevated PSA levels (Prostate-Specific Antigen) may indicate a malignant or benign prostate disease. If PSA levels increase (it may be due to a physical activity or prostate manipulation – necessary to limit prior to examination), the immune system should be strengthened to reinforce the fight against cancer cells. The immune system is a primary factor behind health, its promotion leads to a timely restoration of immunity, and prevention of cancer.
Liver cancer, Brain cancer, Hodgkin´s lymphoma, Cervical cancer, Kidney cancer, Leukemia, Lung cancer, Skin cancer, Uterine cancer, Prostate cancer, Breast cancer, Pancreatic cancer, Colon cancer, Bladder cancer, Ovarian cancer, Testicular cancer, Stomach cancer, Oesophageal cancer, Thymus cancer, Thyroid cancer